Docoh
Loading...

OCUP Ocuphire Pharma

News

From Benzinga Pro
12 Health Care Stocks Moving In Monday's After-Market Session
6 Dec 21
Movers
Gainers
68 Biggest Movers From Wednesday
26 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share.
Mid-Afternoon Market Update: Dow Falls 75 Points; Biofrontera Shares Spike Higher
24 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Wednesday, the Dow traded down 0.21% to 35,738.42 while the NASDAQ rose 0.06% to 15,784.86. The S&P also rose, gaining 0.01% to 4,690.76.
12 Health Care Stocks Moving In Wednesday's Intraday Session
24 Nov 21
Movers
Gainers Biofrontera (NASDAQ:BFRI) shares increased by 160.83% to $6.86 during Wednesday's regular session. The company's market cap stands at $79.5 million.
Mid-Day Market Update: Gap Drops Following Downbeat Q3 Results; Ocuphire Pharma Shares Jump
24 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets
Midway through trading Wednesday, the Dow traded down 0.28% to 35,714.19 while the NASDAQ fell 0.29% to 15,729.96. The S&P also fell, dropping 0.20% to 4,681.42.
40 Stocks Moving In Wednesday's Mid-Day Session
24 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Biofrontera Inc. (NASDAQ: BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
Benzinga's Top Ratings Upgrades, Downgrades For November 24, 2021
24 Nov 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Nov. 24, 2021: KTTA, APVO, TSLA, BFRI, OCUP
24 Nov 21
Pre-Market Outlook
Today's 5 Stock Ideas (Most-Searched Tickers Edition): The list shared below today is the top 5 most-searched tickers in Benzinga Pro over the last 24 hours: Pasithea Therapeutics (KTTA) Aptevo
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
24 Nov 21
Pre-Market Outlook, Markets, Movers
HC Wainwright & Co. Initiates Coverage On Ocuphire Pharma with Buy Rating, Announces Price Target of $26
24 Nov 21
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. analyst Andrew Fein initiates coverage on Ocuphire Pharma (NASDAQ:OCUP) with a Buy rating and announces Price Target of $26.
12 Health Care Stocks Moving In Thursday's After-Market Session
18 Nov 21
Movers
Gainers NeuroOne Medical Tech (NASDAQ:NMTC) stock moved upwards by 6.47% to $2.63 during Thursday's after-market session. The company's market cap stands at $41.4 million.
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
12 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Small Cap, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Ocuphire Pharma Q3 EPS $(0.25) Up From $(0.33) YoY
12 Nov 21
Earnings, News
Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.25) per share. This is a 24.24 percent increase over losses of $(0.33) per share from the same period last year.
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
8 Nov 21
Biotech, Earnings, News, Penny Stocks, Small Cap, IPOs, Top Stories, General
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week.
Ocuphire Invited To Present Clinical Data On Nyxol And APX3330 At American Academy Of Ophthalmology 2021 Annual Meeting And Eyecelerator/AAO Meeting
1 Nov 21
News, FDA, Events
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that
Ocuphire Announces Publications Featuring The Ref-1 Protein, A Transcription Factor Regulator, As A Novel Therapeutic Target For The Treatment Of Neovascular Retinal Diseases
7 Oct 21
News
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for refractive and retinal eye disorders, today announced the publication of
12 Health Care Stocks Moving In Wednesday's After-Market Session
6 Oct 21
Movers
Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 5.4% to $2.73 during Wednesday's after-market session. The company's market cap stands at $35.2 million.
Ocuphire Pharma To Present Data On Phase 2b Trial For APX3330 For Retina At Ophthalmology Innovation Summit Retina@ASRS Innovation Company Showcase Oct. 7 At 10:16 a.m. EDT, Diabetic Symposium Oct. 9 9:51 a.m. EDT
1 Oct 21
Biotech, News, FDA, Events, General
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that its
12 Health Care Stocks Moving In Monday's Pre-Market Session
20 Sep 21
Pre-Market Outlook, Markets, Movers

Press releases

From Benzinga Pro